1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (1812)
  2. Meeting Abstract (932)
  3. Book Section (169)
  4. Review (156)
  5. Editorial (44)
  6. Conference Paper (40)
  7. Guidelines (31)
  8. Miscellaneous (18)
  9. Correspondence (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Molecular Imaging and Therapy Service (3230)
  2. Radiology, Department of (3052)
  3. GSK Faculty (1475)
  4. Sloan Kettering Institute Faculty (1241)
  5. Molecular Pharmacology and Chemistry Program Faculty (1226)
  6. Department of Medicine (983)

More Groups

People
  1. Steven Larson (957)
  2. Heiko Schoder (543)
  3. Neeta Pandit-Taskar (342)
  4. John Humm (281)
  5. Hebert Vargas Alvarez (267)
  6. Lisa Bodei (205)

More People

Years
  1. 2025 (40)
  2. 2024 (129)
  3. 2023 (176)
  4. 2022 (175)
  5. 2021 (197)
  6. 2020 (195)

More Years

Publications
  1. Journal of Nuclear Medicine (569)
  2. Journal of Clinical Oncology (248)
  3. European Journal of Nuclear Medicine and Molecular Imaging (130)
  4. Blood (97)
  5. International Journal of Radiation Oncology, Biology, Physics (73)
  6. Clinical Nuclear Medicine (72)

More Publications

Publishers
  1. Society of Nuclear Medicine (569)
  2. Springer (430)
  3. Elsevier Inc. (303)
  4. American Society of Clinical Oncology (259)
  5. Lippincott Williams & Wilkins (154)
  6. American Association for Cancer Research (150)

More Publishers

Results (3230)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Unravelling tumour heterogeneity using next-generation imaging: Radiomics, radiogenomics, and habitat imaging
    Journal Article

    Sala, E.; Mema, E.; Himoto, Y.; Veeraraghavan, H.; Brenton, J. D.; Snyder, A.; Weigelt, B.; Vargas, H. A.
    Clinical Radiology (2017)

    Fulltext@MSK | Save
  • Radioiodine dosimetry with recombinant human thyrotropin
    Book Section

    Tuttle, R. M.; Grewal, R. K.; Robbins, R. J.
    In Wartofsky, L.; Van Nostrand, D. (Eds.) Thyroid Cancer: A Comprehensive Guide to Clinical Management. 3rd ed (2016)

    Fulltext@MSK | Save
  • Circulating tumour DNA carrying patient-specific mutations in TP53 as an early response biomarker in relapsed high grade serous ovarian cancer
    Meeting Abstract

    Parkinson, C. A.; Gale, D.; Piskorz, A.; Hodgkin, C.; Biggs, H.; Addley, H.; Moyle, P.; Freeman, S.; Sala, E.; Hosking, K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic and metabolic characterization of succinate dehydrogenase B deficient renal cell carcinoma
    Meeting Abstract

    Lee, C. H.; Wei, E.; Lee, W.; Chen, Y.; Mano, R.; Hakimi, A. A.; Dong, Y.; Redzematovic, A.; Cross, J. R.; Tickoo, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Metabolic tumor volume to predict event free survival in patients with relapsed/refractory HL treated with brentuximab vedotin-based salvage therapy
    Meeting Abstract

    Gavane, S. C.; Ito, K.; Moskowitz, C. H.; Moskowitz, A. J.; Schoder, H.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Enhancing radioiodine (RAI) incorporation into BRAF(V600E)-mutant, RAI-refractory thyroid cancers with the BRAF inhibitor vemurafenib: A pilot study
    Meeting Abstract

    Dunn, L.; Sherman, E. J.; Baxi, S. S.; Grewal, R. K.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M.; Fish, S.; Boucai, L.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • IgG4-related kidney disease in a patient with history of breast cancer: Findings on (18)F-FDG PET/CT
    Journal Article

    Krebs, S.; Monti, S.; Seshan, S.; Fox, J.; Mannelli, L.
    Clinical Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Phase III randomized study of R-CHOP versus DA-EPOCH-R and molecular analysis of untreated diffuse large B-cell lymphoma: CALGB/Alliance 50303
    Meeting Abstract

    Wilson, W. H.; Sin-Ho, J.; Pitcher, B. N.; Hsi, E. D.; Friedberg, J.; Cheson, B.; Bartlett, N. L.; Smith, S.; Johnston, N. W.; Kahl, B. S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Interim PET evaluation by Deauville criteria is an effective risk stratification tool in PTCL
    Meeting Abstract

    Mehta-Shah, N.; Ito, K.; Bantilan, K. S.; Moskowitz, A. J.; Sauter, C. S.; Horwitz, S. M.; Schoder, H.
    Blood (2016)

    Fulltext@MSK | Save
  • Vemurafenib in patients with Erdheim-Chester disease (ECD) and Langerhans cell histiocytosis (LCH) harboring BRAF(V600) mutations: A cohort of the histology-independent VE-BASKET study
    Meeting Abstract

    Diamond, E. L.; Subbiah, V.; Lockhart, C.; Blay, J. Y.; Faris, J. E.; Puzanov, I.; Chau, I.; Raje, N. S.; Wolf, J. S.; Erinjeri, J.; more...
    Blood (2016)

    Fulltext@MSK | Save